An Inhibitor of Activated Thrombin-Activatable Fibrinolysis Inhibitor Potentiates Tissue-Type Plasminogen Activator-Induced Thrombolysis in a Rabbit Jugular Vein Thrombolysis Model
- 1 May 2000
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 98 (4), 333-342
- https://doi.org/10.1016/s0049-3848(00)00184-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Thrombomodulin in Human Plasma Contributes to Inhibit Fibrinolysis through Acceleration of Thrombin-dependent Activation of Plasma Procarboxypeptidase BThrombosis and Haemostasis, 1998
- Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor.JCI Insight, 1998
- Both Cellular and Soluble Forms of Thrombomodulin Inhibit Fibrinolysis by Potentiating the Activation of Thrombin-activable Fibrinolysis InhibitorJournal of Biological Chemistry, 1998
- Plasma TAFI Levels Influence the Clot Lysis Time in Healthy Individuals in the Presence of an Intact Intrinsic Pathway of CoagulationThrombosis and Haemostasis, 1998
- Thrombin, Thrombomodulin and TAFI in the Molecular Link Between Coagulation and FibrinolysisThrombosis and Haemostasis, 1997
- On the Mechanism of the Antifibrinolytic Activity of Plasma Carboxypeptidase BJournal of Biological Chemistry, 1997
- TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin ComplexPublished by Elsevier ,1996
- Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis InhibitorJournal of Biological Chemistry, 1995
- Activation and Characterization of Procarboxypeptidase B from Human PlasmaBiochemistry, 1995
- An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunitsBiochemical and Biophysical Research Communications, 1989